Additional file 5: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study

  • Cheng Maw Ho (Contributor)
  • Chih-hsin Lee (Contributor)
  • Ming-Chia Lee (Contributor)
  • Jun Fu Zhang (Contributor)
  • Jann Yuan Wang (Contributor)
  • Rey Heng Hu (Contributor)
  • Po-Huang Lee (Contributor)



Table S3. Duration and amount of HBV medications and interferons in patients who received them in the study period, as grouped according to the use of ACEIs or ARBs within 6Â months after the index date. (DOCX 17Â kb)
Date made availableApr 10 2018
PublisherUnknown Publisher

Cite this